Small Cap Gainers: NRXP, AGFY, ENDP
3:29 pm Thursday, July 22nd, 2021
NRX Pharmaceuticals Inc (NASDAQ: NRXP) stock soared 62% to $16.39 after the company announced that it has validated the first commercial formulation of ZYESAMI for intravenous use, allowing for high volume manufacture, with an anticipated one year or greater stability, under appropriate storage conditions. Co has also achieved a 30-to-50-fold increase in its manufactured lot size of aviptadil.
Agrify Corp (NASDAQ: AGFY) continued strength on elevated volume; the stock has gained approx. +35% through the most recent three sessions. The stock is up by 11.30% to $18.42. Agrify Corporation provides biotechnology products. The Company develops indoor grow solutions, LED grow lights, environmental threat migration, and integrated grow racks for the cannabis and hemp marketplace. Agrify serves customers in the United States.
Endo International PLC (NASDAQ: ENDP) surged 7% after the company announced that its subsidiaries have reached an agreement in principle to settle an opioid-related court case in Tennessee; the settlement would fully and finally resolve the case in exchange for a total payment by co of $35 million, to be apportioned among all 28 plaintiffs. Endo International plc is an American Irish-domiciled generics and specialty branded pharmaceutical company that generated over 93% of its 2017 sales from the U.S. healthcare system. Wikipedia
